Pharmaceuticals: Page 2
This Is Why the U.S. Needs Drug-Pricing Reform
Democrats must deliver on drug-pricing reform while they still hold the White House and Congress.
Johnson & Johnson to Split Into Two Companies, Shares Rally
The new Johnson & Johnson company will focus on the medical devices and pharmaceuticals business, which sells its COVID-19 vaccine and other drugs.
US Trade Deficit Hits Record High as Consumer Goods Imports See Sharp Rise
The Commerce Department said in an Oct. 5 statement that the trade deficit rose by 4.2 percent in August, hitting an all-time high of $73.3 billion.
Pfizer and BioNTech SE Submit Data on Covid Vaccine for Kids 5-11 to FDA; Emergency Use Authorization Could Come By Halloween
The pharmaceutical companies are confident they're one step closer to making vaccination an option for millions of younger children.
From Johnson & Johnson To Israeli Tech Ecosystem
Earlier this year, Richard Serbin joined Canadian-Israeli pharmaceuticals company InnoCan Pharma as a consultant. Now the former Johnson & Johnson Vice President and FDA Counsel is already making a major impact: this month he was a featured speaker with InnoCan's CEO Iris Bincovich at the iCDP Conference in Boston
AstraZeneca Lost Money on COVID-19 Vaccine in First Half of 2021
AstraZeneca said losses on Vaxzevria were the main factor that shaved seven percentage points off its Reported Gross Profit Margin, which fell to 73.5 percent in the first half of the year.
This Top Health-Tech Executive joins the CBD Pharma Industry and Boosts Shareholder Confidence
Since its founding in 2018, InnoCan Pharma has been capturing headlines with its research and development of smart delivery platforms and leading advisory team. Last year, InnoCan added Peter Bloch, one of the industry's foremost health-tech executives
Here's How These Businesses Exploded During the Pandemic
A select group of companies figured out how to not only stay afloat, but also thrive in the midst of this pandemic.
InnoCan Pharma Launches Trading on OTCQB Venture Market
InnoCan Pharma has officially launched common shares trading on the OTCQB Venture Market, placing the promising pharmaceuticals company in the next stage of its strategic commercialization plan
What is Next for InnoCan Pharma After Strategic Advisory Board Addition
After adding Johnson & Johnson's former vice-president of corporate development and FDA counsel to its advisory board, InnoCan Pharma's future seems bright, and investors are taking notice
FDA Says Johnson & Johnson's One-Dose Vaccine Is Safe and Effective
US regulators just released detailed data on Johnson & Johnson's coronavirus vaccine.
Patanjali's Baba Ramdev Plans 'Big Announcement' On Coronil
The medication developed by Patanjali may soon be approved by the government as a valid medication against the COVID-19; company eyes lion's share of nutraceutical market
Amazon Pharmacy Lets You Order Prescription Meds Using an App
Use the Amazon app to get your meds without leaving home and free two-day delivery if you're a Prime subscriber.
InnoCan Pharma Stands With Science To Commercialize CBD
The chief executive officer of the company, Iris Bincovich, talks about the future plans
Purdue Pharma to Plead Guilty to Multiple Federal Charges (Updated)
The OxyContin manufacturer will pay the government $225 million and own up to misleading the DEA and incentivizing doctors to write prescriptions.